Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	410.88	37.43	42.45	53.36	49.07	8.36
Cash & Cash Equivalents	410.88	37.43	42.45	53.36	49.07	8.36
Cash Growth	967.57%	-11.81%	-20.45%	8.74%	486.76%	26.56%
Other Current Assets	2.07	0.16	0.25	1.06	0.9	0.12
Total Current Assets	412.95	37.59	42.7	54.42	49.97	8.48
Property, Plant & Equipment	1.1	0.26	0.37	0.49	0.45	0.03
Other Long-Term Assets	0.04	0.01	0.02	0.02	0.01	0.02
Total Long-Term Assets	1.14	0.27	0.39	0.5	0.46	0.06
Total Assets	414.09	37.86	43.09	54.92	50.43	8.54
Accounts Payable	2.15	0.36	0.33	1.12	1.77	0.42
Current Debt	0.15	0	0	0	0	0
Other Current Liabilities	15.75	0.28	0.8	2.38	1.73	0.51
Total Current Liabilities	18.04	0.64	1.13	3.5	3.5	0.93
Long-Term Debt	0.84	0.2	0.28	0.38	0.41	0
Total Long-Term Liabilities	0.84	0.2	0.28	0.38	0.41	0
Total Liabilities	18.88	0.84	1.41	3.88	3.91	0.93
Total Debt	0.99	0.2	0.28	0.38	0.41	0
Debt Growth	341.07%	-27.14%	-26.89%	-6.36%	-	-
Retained Earnings	-57.94	-188.74	-183.4	-173.48	-154.15	-144.42
Shareholders' Equity	342.37	37.02	41.67	51.04	46.52	7.61
Net Cash / Debt	409.89	37.23	42.17	52.98	48.66	8.36
Net Cash / Debt Growth	971.24%	-11.71%	-20.41%	8.87%	481.87%	26.56%
Net Cash Per Share	27.30	30.99	35.11	45.72	123.97	75.96
Working Capital	394.91	36.96	41.57	50.92	46.47	7.55
Book Value Per Share	22.80	30.82	34.70	44.05	118.52	69.12

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).